Ticker: SGMO
Share drop: -14% on Wednesday, January 9.
What happened: Sangamo tumbled on the day it presented at the J.P. Morgan Healthcare Conference. The company aims to use gene therapies to treat diseases like hemophilia and sickle cell. It told investors to expect some updates on two trials of treatments for metabolic diseases in February, but that other info on the trials won't be available at that time.
You can see the company's slide presentation here.